These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2173469)

  • 21. [Immunohistochemistry of biomolecular markers of lung cancer].
    Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K
    Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
    J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
    Volm M
    Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
    Pechoux C; Chardonnet Y; Chignol MC; Noël P
    Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.
    Gosney JR; Field JK; Gosney MA; Lye MD; Spandidos DA; Butt SA
    Anticancer Res; 1990; 10(3):623-8. PubMed ID: 2164348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.
    Koutsopoulos AV; Mavroudis D; Dambaki KI; Souglakos J; Tzortzaki EG; Drositis J; Delides GS; Georgoulias V; Stathopoulos EN
    Lung Cancer; 2007 Aug; 57(2):193-200. PubMed ID: 17442448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
    Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype.
    Volm M; Koomägi R; Efferth T; Mattern J
    Anticancer Res; 2002; 22(4):2321-4. PubMed ID: 12174921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental study of the expression of c-myc, c-fos and proto-oncogenes on hypertrophic and scars].
    Hu Z; Lou L; Luo S
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2002 May; 18(3):165-7. PubMed ID: 12189705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas.
    Kakinuma H; Mikami T; Iwabuchi K; Yokoyama M; Hattori M; Ohno E; Kuramoto H; Jiang SX; Okayasu I
    Cancer; 2003 Aug; 99(4):247-54. PubMed ID: 12925987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression pattern of the scaffold protein IQGAP1 in lung cancer.
    Nakamura H; Fujita K; Nakagawa H; Kishi F; Takeuchi A; Aute I; Kato H
    Oncol Rep; 2005 Mar; 13(3):427-31. PubMed ID: 15706411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical study of p53, EGF, EGF-receptor, v-erb B and ras p21 in squamous cell carcinoma of hypopharynx.
    Otsu M; Hayashi Y; Amatsu M; Itoh H
    Kobe J Med Sci; 1994 Dec; 40(5-6):139-53. PubMed ID: 7616733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides.
    Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA
    Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
    Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
    Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
    Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.